Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound hypertonic salt solution refers to a sterile intravenous formulation containing a higher-than-physiological concentration of sodium chloride (NaCl), often combined with other salts such as sodium acetate. These solutions are used for rapid correction of severe hyponatremia, management of increased intracranial pressure in traumatic brain injury or cerebral edema, and volume resuscitation in critical care settings. The mechanism involves creating an osmotic gradient that draws water out of cells into the extracellular space and bloodstream, thereby increasing serum sodium levels and reducing cerebral edema. Typical formulations include 2% or 3% NaCl combined with equimolar amounts of sodium acetate in sterile water[5][8]. The exact composition may vary depending on clinical need but is always more concentrated than normal (0.9%) saline.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound hypertonic salt solution.